
Julie Ha
Examiner (ID: 17647, Phone: (571)272-5982 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675 |
| Total Applications | 1488 |
| Issued Applications | 934 |
| Pending Applications | 118 |
| Abandoned Applications | 454 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18055588
[patent_doc_number] => 20220386674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => USE OF ALPHA-LACTALBUMIN ENRICHED WHEY PROTEIN EXTRACT AS A SOURCE OF CHOLESTEROL
[patent_app_type] => utility
[patent_app_number] => 17/755939
[patent_app_country] => US
[patent_app_date] => 2020-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5870
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/755939 | USE OF ALPHA-LACTALBUMIN ENRICHED WHEY PROTEIN EXTRACT AS A SOURCE OF CHOLESTEROL | Nov 8, 2020 | Pending |
Array
(
[id] => 16791730
[patent_doc_number] => 20210121547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => PROGESTERONE-ASSOCIATED ENDOMETRIAL PROTEIN (PAEP) AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/092715
[patent_app_country] => US
[patent_app_date] => 2020-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17092715
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/092715 | PROGESTERONE-ASSOCIATED ENDOMETRIAL PROTEIN (PAEP) AND USES THEREOF | Nov 8, 2020 | Abandoned |
Array
(
[id] => 16792967
[patent_doc_number] => 20210122784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => PEPTIDES DERIVED FROM SOLUTE CARRIER FAMILY 45 MEMBER 2 (SLC45A2) AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/092970
[patent_app_country] => US
[patent_app_date] => 2020-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9939
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17092970
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/092970 | PEPTIDES DERIVED FROM SOLUTE CARRIER FAMILY 45 MEMBER 2 (SLC45A2) AND USES THEREOF | Nov 8, 2020 | Abandoned |
Array
(
[id] => 18478281
[patent_doc_number] => 11692011
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Hepatitis B virus-derived polypeptide and anti-viral use thereof
[patent_app_type] => utility
[patent_app_number] => 17/090485
[patent_app_country] => US
[patent_app_date] => 2020-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 40
[patent_no_of_words] => 9537
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17090485
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/090485 | Hepatitis B virus-derived polypeptide and anti-viral use thereof | Nov 4, 2020 | Issued |
Array
(
[id] => 17435910
[patent_doc_number] => 11261222
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-01
[patent_title] => Transdermal peptide with nuclear localization ability and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/090125
[patent_app_country] => US
[patent_app_date] => 2020-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 3799
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17090125
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/090125 | Transdermal peptide with nuclear localization ability and use thereof | Nov 4, 2020 | Issued |
Array
(
[id] => 17007076
[patent_doc_number] => 20210238237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => METHOD OF MANAGING JOINT PAIN
[patent_app_type] => utility
[patent_app_number] => 17/085023
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085023
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/085023 | Method of managing joint pain | Oct 29, 2020 | Issued |
Array
(
[id] => 18559802
[patent_doc_number] => 11725036
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Modified lipidated relaxin B chain peptides and their therapeutic use
[patent_app_type] => utility
[patent_app_number] => 17/086183
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16838
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17086183
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/086183 | Modified lipidated relaxin B chain peptides and their therapeutic use | Oct 29, 2020 | Issued |
Array
(
[id] => 18364942
[patent_doc_number] => 20230146533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => KERATIN BD-10, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/772756
[patent_app_country] => US
[patent_app_date] => 2020-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17772756
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/772756 | KERATIN BD-10, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | Oct 27, 2020 | Abandoned |
Array
(
[id] => 16715390
[patent_doc_number] => 20210082537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => SELECTIVE PEPTIDE ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/083099
[patent_app_country] => US
[patent_app_date] => 2020-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083099
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/083099 | Selective peptide antagonists | Oct 27, 2020 | Issued |
Array
(
[id] => 16990270
[patent_doc_number] => 20210228690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => Anti-Inflammatory Peptides and Composition Comprising the Same
[patent_app_type] => utility
[patent_app_number] => 17/080653
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17080653
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/080653 | Anti-inflammatory peptides and composition comprising the same | Oct 25, 2020 | Issued |
Array
(
[id] => 20187091
[patent_doc_number] => 12398196
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Fused polypeptide with multifunctional activities and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/635962
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 2431
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17635962
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/635962 | Fused polypeptide with multifunctional activities and use thereof | Oct 25, 2020 | Issued |
Array
(
[id] => 16620051
[patent_doc_number] => 20210038704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => H3.3 CTL PEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/077806
[patent_app_country] => US
[patent_app_date] => 2020-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17077806
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/077806 | H3.3 CTL peptides and uses thereof | Oct 21, 2020 | Issued |
Array
(
[id] => 17741460
[patent_doc_number] => 11389505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Method of managing joint pain
[patent_app_type] => utility
[patent_app_number] => 17/067278
[patent_app_country] => US
[patent_app_date] => 2020-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11337
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17067278
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/067278 | Method of managing joint pain | Oct 8, 2020 | Issued |
Array
(
[id] => 18747053
[patent_doc_number] => 11806342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Diiodohydroxyquinoline for the treatment of clostridium difficile infection
[patent_app_type] => utility
[patent_app_number] => 17/063750
[patent_app_country] => US
[patent_app_date] => 2020-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9007
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063750
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/063750 | Diiodohydroxyquinoline for the treatment of clostridium difficile infection | Oct 5, 2020 | Issued |
Array
(
[id] => 20262862
[patent_doc_number] => 12433830
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => Anti-aging compositions and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/762817
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6326
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762817
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/762817 | Anti-aging compositions and methods of use thereof | Sep 22, 2020 | Issued |
Array
(
[id] => 18056197
[patent_doc_number] => 20220387283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => HAIR GROWTH AGENT
[patent_app_type] => utility
[patent_app_number] => 17/769990
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769990
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769990 | HAIR GROWTH AGENT | Sep 22, 2020 | Abandoned |
Array
(
[id] => 17881206
[patent_doc_number] => 20220296683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => ORAL DELIVERY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/762225
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762225
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/762225 | ORAL DELIVERY SYSTEM | Sep 20, 2020 | Abandoned |
Array
(
[id] => 16569148
[patent_doc_number] => 20210008154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => METHODS AND REAGENTS FOR EFFICIENT AND TARGETED DELIVERY OF THERAPEUTIC MOLECULES TO CXCR4 CELLS
[patent_app_type] => utility
[patent_app_number] => 17/026543
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17026543
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/026543 | Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells | Sep 20, 2020 | Issued |
Array
(
[id] => 18056524
[patent_doc_number] => 20220387610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => PEPTIDE-CONJUGATED PRODRUGS
[patent_app_type] => utility
[patent_app_number] => 17/761496
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23256
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761496
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761496 | Peptide-conjugated prodrugs | Sep 17, 2020 | Issued |
Array
(
[id] => 18518512
[patent_doc_number] => 11708392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Peptide conjugates
[patent_app_type] => utility
[patent_app_number] => 17/012724
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 44
[patent_no_of_words] => 35551
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012724
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/012724 | Peptide conjugates | Sep 3, 2020 | Issued |